biologic

  • BMS, Innate Pharma announce agreement on immuno-oncology biologic

    Bristol-Myers Squibb Company and Innate Pharma SA announced a global agreement for the development and commercialization of IPH2102, a novel antibody in phase 1 development for the treatment of cancer. Under the terms of the agreement, Innate Pha…

    biologic | 07 July 2011

  • Study shows higher rates of clinical, microbiological success for Zyvox

    Results of an international phase 4 study of patients with nosocomial pneumonia due to proven methicillin-resistant staphylococcus aureus (MRSA) demonstrated that the antibiotic Pfizer ’s Zyvox (linezolid) achieved a statistically significantly hig…

    biologic | 18 March 2011

  • Going from chemical to biological

    Recently, NICK ROELOFS, president of Agilent’s life science group, was in Singapore for the opening of a new manufacturing facility. LEE KOK LEONG interviews him.

    biologic | 01 January 2011

  • Inno Biologics scores two firsts

    Inno Biologic has set two new landmarks: delivering the first batch of made-in-Malaysia clinical grade biopharma material and securing a letterof- intent to commercially manufacture biosimilars from India’s Avesthagen. Tapped in April 2010 to deve…

    biologic | 01 January 2011

  • Bigger market share for RA biologic treatments

    Use of biologic disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis is set to increase dramatically over the next five years, says independent market analyst Datamonitor . Despite their considerable cost, rheum…

    biologic | 15 October 2010

  • Genevac: high capacity biological sample concentrator

    For laboratories looking to concentrate larger numbers of biological samples presented in a range of different formats, miVac Quattro from Genevac offers the high capacity sample concentrator. It rapidly removes a wide range of solvents, from vo…

    biologic | 01 August 2010

  • Biologics Price Competition and Innovation Act

    The Patient Protection and Affordable Care Act (PPAC Act), signed into law by US President Obama on March 23, 2010, amends the Public Health Service Act (PHS Act) to create an abbreviated approval pathway for biological products that are demonstrated…

    biologic | 28 June 2010

  • Genedata Provides Knowledge Management System to Bayer Schering

    Genedata and Bayer Schering Pharma have announced a multi-year collaboration for the development and implementation of the Biologics Data Platform (BDP). The platform will support biologics data management and analysis at the latter’s R&D sites…

    biologic | 08 January 2010

  • Cevec Signs Agreement with Inno Biologics in Malaysia

    Cevec Pharmaceuticals and the contract manufacturer Inno Biologics, Malaysia, have announced the signing of a strategic license agreement. This license enables the latter to offer the full potential of production of their diagnostic and preclinical g…

    biologic | 31 December 2009

  • Roche Opens Biologics Manufacturing Site in Asia Pacific

    Roche has held the dedication ceremony for its biologics manufacturing site in Singapore at the Tuas Biomedical Park. The fully-owned subsidiary is established in Singapore under the name Roche Singapore Technical Operations. With a combined…

    biologic | 01 November 2009

Page 1 Next > Last >>